Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.S6.a
Macrì S et al. (2016)
|
Xla Wt + hmga2-EnR
NF25 (in situ hybridization)
|
|
|
|
fig.S6.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF13-18 (in situ hybridization)
|
|
|
|
fig.5.a
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF13 (in situ hybridization)
|
|
|
|
fig.5.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.S3. d, f
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF16 (in situ hybridization)
|
|
|
|
fig.S5. a
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF17 (in situ hybridization)
|
|
|
|
fig.S5.c
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF17 (in situ hybridization)
|
|
|
|
fig.S5.e
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF17 (in situ hybridization)
|
|
|
|
fig.S3. a, c
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF18 (in situ hybridization)
|
|
|
|
fig.S6.b
Macrì S et al. (2016)
|
Xla Wt + hmga2 MO
NF22-25 (in situ hybridization)
|
|
|